Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileFiona Mary Fennessy, PH.D., M.D.

TitleAssociate Professor of Radiology
InstitutionDana-Farber Cancer Institute
DepartmentRadiology
AddressDana Farber Cancer Institute
Dept. of Radiology, Office # L188
44 Binney St
Boston MA 02115
Phone617/632-4785
Fax617/632-3505
vCardDownload vCard (login for email)

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Newitt DC, Malyarenko D, Chenevert TL, Quarles CC, Bell L, Fedorov A, Fennessy F, Jacobs MA, Solaiyappan M, Hectors S, Taouli B, Muzi M, Kinahan PE, Schmainda KM, Prah MA, Taber EN, Kroenke C, Huang W, Arlinghaus LR, Yankeelov TE, Cao Y, Aryal M, Yen YF, Kalpathy-Cramer J, Shukla-Dave A, Fung M, Liang J, Boss M, Hylton N. Multisite concordance of apparent diffusion coefficient measurements across the NCI Quantitative Imaging Network. J Med Imaging (Bellingham). 2018 Jan; 5(1):011003. PMID: 29021993.
    View in: PubMed
  2. Bane O, Hectors SJ, Wagner M, Arlinghaus LL, Aryal MP, Cao Y, Chenevert TL, Fennessy F, Huang W, Hylton NM, Kalpathy-Cramer J, Keenan KE, Malyarenko DI, Mulkern RV, Newitt DC, Russek SE, Stupic KF, Tudorica A, Wilmes LJ, Yankeelov TE, Yen YF, Boss MA, Taouli B. Accuracy, repeatability, and interplatform reproducibility of T1 quantification methods used for DCE-MRI: Results from a multicenter phantom study. Magn Reson Med. 2017 Sep 14. PMID: 28913930.
    View in: PubMed
  3. Fedorov A, Vangel MG, Tempany CM, Fennessy FM. Multiparametric Magnetic Resonance Imaging of the Prostate: Repeatability of Volume and Apparent Diffusion Coefficient Quantification. Invest Radiol. 2017 Sep; 52(9):538-546. PMID: 28463931.
    View in: PubMed
  4. Hassanzadeh E, Alessandrino F, Olubiyi OI, Glazer DI, Mulkern RV, Fedorov A, Tempany CM, Fennessy FM. Comparison of quantitative apparent diffusion coefficient parameters with prostate imaging reporting and data system V2 assessment for detection of clinically significant peripheral zone prostate cancer. Abdom Radiol (NY). 2017 Aug 24. PMID: 28840280.
    View in: PubMed
  5. Krajewski KM, Howard SA, Shinagare AB, Van den Abbeele AD, Fennessy FM. Cancer Imaging Fellowship Training: Utility and Added Value in the Modern Era. J Am Coll Radiol. 2017 Oct; 14(10):1345-1348. PMID: 28697959.
    View in: PubMed
  6. Rios Velazquez E, Parmar C, Liu Y, Coroller TP, Cruz G, Stringfield O, Ye Z, Makrigiorgos M, Fennessy F, Mak RH, Gillies R, Quackenbush J, Aerts HJWL. Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer. Cancer Res. 2017 Jul 15; 77(14):3922-3930. PMID: 28566328.
    View in: PubMed
  7. Abbosh C, Birkbak NJ, Wilson GA, Jamal-Hanjani M, Constantin T, Salari R, Le Quesne J, Moore DA, Veeriah S, Rosenthal R, Marafioti T, Kirkizlar E, Watkins TBK, McGranahan N, Ward S, Martinson L, Riley J, Fraioli F, Al Bakir M, Grönroos E, Zambrana F, Endozo R, Bi WL, Fennessy FM, Sponer N, Johnson D, Laycock J, Shafi S, Czyzewska-Khan J, Rowan A, Chambers T, Matthews N, Turajlic S, Hiley C, Lee SM, Forster MD, Ahmad T, Falzon M, Borg E, Lawrence D, Hayward M, Kolvekar S, Panagiotopoulos N, Janes SM, Thakrar R, Ahmed A, Blackhall F, Summers Y, Hafez D, Naik A, Ganguly A, Kareht S, Shah R, Joseph L, Marie Quinn A, Crosbie PA, Naidu B, Middleton G, Langman G, Trotter S, Nicolson M, Remmen H, Kerr K, Chetty M, Gomersall L, Fennell DA, Nakas A, Rathinam S, Anand G, Khan S, Russell P, Ezhil V, Ismail B, Irvin-Sellers M, Prakash V, Lester JF, Kornaszewska M, Attanoos R, Adams H, Davies H, Oukrif D, Akarca AU, Hartley JA, Lowe HL, Lock S, Iles N, Bell H, Ngai Y, Elgar G, Szallasi Z, Schwarz RF, Herrero J, Stewart A, Quezada SA, Peggs KS, Van Loo P, Dive C, Lin CJ, Rabinowitz M, Aerts HJWL, Hackshaw A, Shaw JA, Zimmermann BG, Swanton C. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature. 2017 04 26; 545(7655):446-451. PMID: 28445469.
    View in: PubMed
  8. Glazer DI, Hassanzadeh E, Fedorov A, Olubiyi OI, Goldberger SS, Penzkofer T, Flood TA, Masry P, Mulkern RV, Hirsch MS, Tempany CM, Fennessy FM. Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology. Abdom Radiol (NY). 2017 Mar; 42(3):918-925. PMID: 27770164.
    View in: PubMed
  9. Hassanzadeh E, Glazer DI, Dunne RM, Fennessy FM, Harisinghani MG, Tempany CM. Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review. Abdom Radiol (NY). 2017 Jan; 42(1):278-289. PMID: 27522352.
    View in: PubMed
  10. Gibson WJ, Ruan DT, Paulson VA, Barletta JA, Hanna GJ, Kraft S, Calles A, Nehs MA, Moore FD, Taylor-Weiner A, Wala JA, Zack TI, Lee TC, Fennessy FM, Alexander EK, Thomas T, Janne PA, Garraway LA, Carter SL, Beroukhim R, Lorch JH, Van Allen EM. Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer. Clin Cancer Res. 2017 May 01; 23(9):2367-2373. PMID: 27797976.
    View in: PubMed
  11. Ciris PA, Balasubramanian M, Seethamraju RT, Tokuda J, Scalera J, Penzkofer T, Fennessy FM, Tempany-Afdhal CM, Tuncali K, Mulkern RV. Characterization of gradient echo signal decays in healthy and cancerous prostate at 3T improves with a Gaussian augmentation of the mono-exponential (GAME) model. NMR Biomed. 2016 Jul; 29(7):999-1009. PMID: 27241215; PMCID: PMC4957529.
  12. Huang W, Chen Y, Fedorov A, Li X, Jajamovich GH, Malyarenko DI, Aryal MP, LaViolette PS, Oborski MJ, O'Sullivan F, Abramson RG, Jafari-Khouzani K, Afzal A, Tudorica A, Moloney B, Gupta SN, Besa C, Kalpathy-Cramer J, Mountz JM, Laymon CM, Muzi M, Schmainda K, Cao Y, Chenevert TL, Taouli B, Yankeelov TE, Fennessy F, Li X. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge. Tomography. 2016 Mar; 2(1):56-66. PMID: 27200418.
    View in: PubMed
  13. Mehrtash A, Gupta SN, Shanbhag D, Miller JV, Kapur T, Fennessy FM, Kikinis R, Fedorov A. Bolus arrival time and its effect on tissue characterization with dynamic contrast-enhanced magnetic resonance imaging. J Med Imaging (Bellingham). 2016 Jan; 3(1):014503. PMID: 26989759; PMCID: PMC4773735 [Available on 03/01/17].
  14. Yankeelov TE, Mankoff DA, Schwartz LH, Lieberman FS, Buatti JM, Mountz JM, Erickson BJ, Fennessy FM, Huang W, Kalpathy-Cramer J, Wahl RL, Linden HM, Kinahan PE, Zhao B, Hylton NM, Gillies RJ, Clarke L, Nordstrom R, Rubin DL. Quantitative Imaging in Cancer Clinical Trials. Clin Cancer Res. 2016 Jan 15; 22(2):284-90. PMID: 26773162; PMCID: PMC4717912 [Available on 01/15/17].
  15. Van den Abbeele AD, Krajewski KM, Tirumani SH, Fennessy FM, DiPiro PJ, Nguyen QD, Harris GJ, Jacene HA, Lefever G, Ramaiya NH. Cancer Imaging at the Crossroads of Precision Medicine: Perspective From an Academic Imaging Department in a Comprehensive Cancer Center. J Am Coll Radiol. 2016 Apr; 13(4):365-71. PMID: 26774886.
    View in: PubMed
  16. Fischer K, McDannold NJ, Tempany CM, Jolesz FA, Fennessy FM. Potential of minimally invasive procedures in the treatment of uterine fibroids: a focus on magnetic resonance-guided focused ultrasound therapy. Int J Womens Health. 2015; 7:901-12. PMID: 26622192; PMCID: PMC4654554.
  17. Yamauchi FI, Penzkofer T, Fedorov A, Fennessy FM, Chu R, Maier SE, Tempany CM, Mulkern RV, Panych LP. Prostate cancer discrimination in the peripheral zone with a reduced field-of-view T(2)-mapping MRI sequence. Magn Reson Imaging. 2015 Jun; 33(5):525-30. PMID: 25687187; PMCID: PMC4426240.
  18. Fennessy FM, Fedorov A, Penzkofer T, Kim KW, Hirsch MS, Vangel MG, Masry P, Flood TA, Chang MC, Tempany CM, Mulkern RV, Gupta SN. Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation. Magn Reson Imaging. 2015 Sep; 33(7):886-94. PMID: 25683515; PMCID: PMC4465997.
  19. Fedorov A, Penzkofer T, Hirsch MS, Flood TA, Vangel MG, Masry P, Tempany CM, Mulkern RV, Fennessy FM. The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI. Acad Radiol. 2015 May; 22(5):548-55. PMID: 25683501; PMCID: PMC4429788.
  20. Howard SA, Gray KP, O'Donnell EK, Fennessy FM, Beard CJ, Sweeney CJ. Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumor. AJR Am J Roentgenol. 2014 Oct; 203(4):W415-20. PMID: 25247970.
    View in: PubMed
  21. Tilak G, Tuncali K, Song SE, Tokuda J, Olubiyi O, Fennessy F, Fedorov A, Penzkofer T, Tempany C, Hata N. 3T MR-guided in-bore transperineal prostate biopsy: A comparison of robotic and manual needle-guidance templates. J Magn Reson Imaging. 2015 Jul; 42(1):63-71. PMID: 25263213; PMCID: PMC4376663.
  22. Penzkofer T, Tuncali K, Fedorov A, Song SE, Tokuda J, Fennessy FM, Vangel MG, Kibel AS, Mulkern RV, Wells WM, Hata N, Tempany CM. Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study. Radiology. 2015 Jan; 274(1):170-80. PMID: 25222067; PMCID: PMC4334270.
  23. Murciano-Goroff YR, Wolfsberger LD, Parekh A, Fennessy FM, Tuncali K, Orio PF, Niedermayr TR, Suh WW, Devlin PM, Tempany CM, Sugar EH, O'Farrell DA, Steele G, O'Leary M, Buzurovic I, Damato AL, Cormack RA, Fedorov AY, Nguyen PL. Variability in MRI vs. ultrasound measures of prostate volume and its impact on treatment recommendations for favorable-risk prostate cancer patients: a case series. Radiat Oncol. 2014 Sep 09; 9:200. PMID: 25205146; PMCID: PMC4261899.
  24. Kong CY, Meng L, Omer ZB, Swan JS, Srouji S, Gazelle GS, Fennessy FM. MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis. AJR Am J Roentgenol. 2014 Aug; 203(2):361-71. PMID: 25055272; PMCID: PMC4321860.
  25. Mountz JM, Yankeelov TE, Rubin DL, Buatti JM, Erikson BJ, Fennessy FM, Gillies RJ, Huang W, Jacobs MA, Kinahan PE, Laymon CM, Linden HM, Mankoff DA, Schwartz LH, Shim H, Wahl RL. Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials. J Clin Oncol. 2014 Jul 01; 32(19):2115-6. PMID: 24868025; PMCID: PMC4861229.
  26. Hurwitz MD, Ghanouni P, Kanaev SV, Iozeffi D, Gianfelice D, Fennessy FM, Kuten A, Meyer JE, LeBlang SD, Roberts A, Choi J, Larner JM, Napoli A, Turkevich VG, Inbar Y, Tempany CM, Pfeffer RM. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results. J Natl Cancer Inst. 2014 Apr 23; 106(5). PMID: 24760791; PMCID: PMC4112926.
  27. Chenevert TL, Malyarenko DI, Newitt D, Li X, Jayatilake M, Tudorica A, Fedorov A, Kikinis R, Liu TT, Muzi M, Oborski MJ, Laymon CM, Li X, Thomas Y, Jayashree KC, Mountz JM, Kinahan PE, Rubin DL, Fennessy F, Huang W, Hylton N, Ross BD. Errors in Quantitative Image Analysis due to Platform-Dependent Image Scaling. Transl Oncol. 2014 Feb; 7(1):65-71. PMID: 24772209; PMCID: PMC3998685.
  28. Huang W, Li X, Chen Y, Li X, Chang MC, Oborski MJ, Malyarenko DI, Muzi M, Jajamovich GH, Fedorov A, Tudorica A, Gupta SN, Laymon CM, Marro KI, Dyvorne HA, Miller JV, Barbodiak DP, Chenevert TL, Yankeelov TE, Mountz JM, Kinahan PE, Kikinis R, Taouli B, Fennessy F, Kalpathy-Cramer J. Variations of dynamic contrast-enhanced magnetic resonance imaging in evaluation of breast cancer therapy response: a multicenter data analysis challenge. Transl Oncol. 2014 Feb; 7(1):153-66. PMID: 24772219; PMCID: PMC3998693.
  29. Fennessy FM, McKay RR, Beard CJ, Taplin ME, Tempany CM. Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer clinical trials: potential roles and possible pitfalls. Transl Oncol. 2014 Feb; 7(1):120-9. PMID: 24772215; PMCID: PMC3998683.
  30. Fedorov A, Fluckiger J, Ayers GD, Li X, Gupta SN, Tempany C, Mulkern R, Yankeelov TE, Fennessy FM. A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation. Magn Reson Imaging. 2014 May; 32(4):321-9. PMID: 24560287; PMCID: PMC3965600.
  31. Velazquez ER, Parmar C, Jermoumi M, Mak RH, van Baardwijk A, Fennessy FM, Lewis JH, De Ruysscher D, Kikinis R, Lambin P, Aerts HJ. Volumetric CT-based segmentation of NSCLC using 3D-Slicer. Sci Rep. 2013 Dec 18; 3:3529. PMID: 24346241; PMCID: PMC3866632.
  32. Machtinger R, Fennessy FM, Stewart EA, Missmer SA, Correia KF, Tempany CM. MR-guided focused ultrasound (MRgFUS) is effective for the distinct pattern of uterine fibroids seen in African-American women: data from phase III/IV, non-randomized, multicenter clinical trials. J Ther Ultrasound. 2013; 1:23. PMID: 25232480; PMCID: PMC4155772.
  33. Galsky MD, Xie W, Nakabayashi M, Ross RW, Fennessy FM, Tempany CM, Choueiri TK, Khine K, Kantoff PW, Taplin ME, Oh WK. Analysis of the correlation between endorectal MRI response to neoadjuvant chemotherapy and biochemical recurrence in patients with high-risk localized prostate cancer. Prostate Cancer Prostatic Dis. 2013 Sep; 16(3):266-70. PMID: 23712318; PMCID: PMC4026061.
  34. Hegde JV, Mulkern RV, Panych LP, Fennessy FM, Fedorov A, Maier SE, Tempany CM. Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging. 2013 May; 37(5):1035-54. PMID: 23606141; PMCID: PMC3741996.
  35. Xie W, Nakabayashi M, Ross RW, Fennessy FM, Tempany CM, Choueiri TK, Khine K, Kantoff PW, Taplin ME, Oh WK. Paradoxical significance of endorectal MRI (erMRI) response to neoadjuvant chemotherapy in patients with high-risk localized prostate cancer (HRLPC). J Clin Oncol. 2013 Feb 20; 31(6_suppl):23. PMID: 28136935.
    View in: PubMed
  36. Pursley J, Risholm P, Fedorov A, Tuncali K, Fennessy FM, Wells WM, Tempany CM, Cormack RA. A Bayesian nonrigid registration method to enhance intraoperative target definition in image-guided prostate procedures through uncertainty characterization. Med Phys. 2012 Nov; 39(11):6858-67. PMID: 23127078; PMCID: PMC3494726.
  37. Hegde JV, Chen MH, Mulkern RV, Fennessy FM, D'Amico AV, Tempany CM. Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):e101-7. PMID: 23040223; PMCID: PMC3545042.
  38. Tokuda J, Tuncali K, Iordachita I, Song SE, Fedorov A, Oguro S, Lasso A, Fennessy FM, Tempany CM, Hata N. In-bore setup and software for 3T MRI-guided transperineal prostate biopsy. Phys Med Biol. 2012 Sep 21; 57(18):5823-40. PMID: 22951350; PMCID: PMC3517895.
  39. Kurland BF, Gerstner ER, Mountz JM, Schwartz LH, Ryan CW, Graham MM, Buatti JM, Fennessy FM, Eikman EA, Kumar V, Forster KM, Wahl RL, Lieberman FS. Promise and pitfalls of quantitative imaging in oncology clinical trials. Magn Reson Imaging. 2012 Nov; 30(9):1301-12. PMID: 22898682; PMCID: PMC3466405.
  40. Fennessy FM, Fedorov A, Gupta SN, Schmidt EJ, Tempany CM, Mulkern RV. Practical considerations in T1 mapping of prostate for dynamic contrast enhancement pharmacokinetic analyses. Magn Reson Imaging. 2012 Nov; 30(9):1224-33. PMID: 22898681; PMCID: PMC3466364.
  41. Levy MA, Freymann JB, Kirby JS, Fedorov A, Fennessy FM, Eschrich SA, Berglund AE, Fenstermacher DA, Tan Y, Guo X, Casavant TL, Brown BJ, Braun TA, Dekker A, Roelofs E, Mountz JM, Boada F, Laymon C, Oborski M, Rubin DL. Informatics methods to enable sharing of quantitative imaging research data. Magn Reson Imaging. 2012 Nov; 30(9):1249-56. PMID: 22770688; PMCID: PMC3466343.
  42. Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, Bauer C, Jennings D, Fennessy F, Sonka M, Buatti J, Aylward S, Miller JV, Pieper S, Kikinis R. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012 Nov; 30(9):1323-41. PMID: 22770690; PMCID: PMC3466397.
  43. Saboo SS, Fennessy F, Benajiba L, Laubach J, Anderson KC, Richardson PG. Imaging features of extramedullary, relapsed, and refractory multiple myeloma involving the liver across treatment with cyclophosphamide, lenalidomide, bortezomib, and dexamethasone. J Clin Oncol. 2012 Jul 10; 30(20):e175-9. PMID: 22689802; PMCID: PMC4874151.
  44. Fedorov A, Tuncali K, Fennessy FM, Tokuda J, Hata N, Wells WM, Kikinis R, Tempany CM. Image registration for targeted MRI-guided transperineal prostate biopsy. J Magn Reson Imaging. 2012 Oct; 36(4):987-92. PMID: 22645031; PMCID: PMC3434292.
  45. Murciano-Goroff YR, Wolfsberger LD, Parekh A, Fennessy FM, Tuncali K, Orio PF, Niedermayr T, Suh WW, Devlin PM, Tempany CM, Nguyen PL. Variability in prostate volume as determined by MRI versus ultrasound and its impact on treatment recommendations for patients with favorable-risk prostate cancer. J Clin Oncol. 2012 Feb 10; 30(5_suppl):249. PMID: 28143244.
    View in: PubMed
  46. Ross RW, Galsky MD, Febbo P, Barry M, Richie JP, Xie W, Fennessy FM, Bhatt RS, Hayes J, Choueiri TK, Tempany CM, Kantoff PW, Taplin ME, Oh WK. Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial. Cancer. 2012 Oct 01; 118(19):4777-84. PMID: 22282219; PMCID: PMC3791849.
  47. Dabora SL, Franz DN, Ashwal S, Sagalowsky A, DiMario FJ, Miles D, Cutler D, Krueger D, Uppot RN, Rabenou R, Camposano S, Paolini J, Fennessy F, Lee N, Woodrum C, Manola J, Garber J, Thiele EA. Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease. PLoS One. 2011; 6(9):e23379. PMID: 21915260; PMCID: PMC3167813.
  48. Fennessy FM, Tempany CM, Jolesz FA, Stewart EA. Re: "ACR Appropriateness Criteria® on treatment of uterine leiomyomas". J Am Coll Radiol. 2011 Sep; 8(9):e1-2; author reply e2-3. PMID: 21889739.
    View in: PubMed
  49. Shinagare AB, Fennessy FM, Ramaiya NH, Jagannathan JP, Taplin ME, Van den Abbeele AD. Urothelial cancers of the upper urinary tract: metastatic pattern and its correlation with tumor histopathology and location. J Comput Assist Tomogr. 2011 Mar-Apr; 35(2):217-22. PMID: 21412093.
    View in: PubMed
  50. Fennessy FM, Kong CY, Tempany CM, Swan JS. Quality-of-life assessment of fibroid treatment options and outcomes. Radiology. 2011 Jun; 259(3):785-92. PMID: 21364084; PMCID: PMC3099045.
  51. Shinagare AB, Cunto-Amesty G, Fennessy FM. Multiple inflammatory nodules: a differential diagnosis of new pulmonary nodules in oncology patients. Cancer Imaging. 2011 Feb 03; 10:205-8. PMID: 21300598; PMCID: PMC3080115.
  52. Shinagare AB, Ramaiya NH, Jagannathan JP, Fennessy FM, Taplin ME, Van den Abbeele AD. Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor. AJR Am J Roentgenol. 2011 Jan; 196(1):117-22. PMID: 21178055.
    View in: PubMed
  53. Machtinger R, Tempany CM, Kanan Roddy A, Fennessy FM. Successful MRI-Guided Focused Ultrasound Uterine Fibroid Treatment Despite an Ostomy and Significant Abdominal Wall Scarring. ISRN Obstet Gynecol. 2011; 2011:962621. PMID: 21647219; PMCID: PMC3100577.
  54. Souza FF, Fennessy FM, Yang Q, van den Abbeele AD. Case report. PET/CT appearance of desmoid tumour of the chest wall. Br J Radiol. 2010 Feb; 83(986):e39-42. PMID: 20139256; PMCID: PMC3473531.
  55. Fennessy FM, Tuncali K, Morrison PR, Tempany CM. MR imaging-guided interventions in the genitourinary tract: an evolving concept. Magn Reson Imaging Clin N Am. 2010 Feb; 18(1):11-28. PMID: 19962090; PMCID: PMC4072848.
  56. Oh WK, Febbo PG, Richie JP, Fennessy FM, Scibelli G, Hayes JH, Choueiri TK, Tempany CM, Taplin ME, Ross RW. A phase II study of neoadjuvant chemotherapy with docetaxel and bevacizumab in patients (pts) with high-risk localized prostate cancer: A Prostate Cancer Clinical Trials Consortium trial. J Clin Oncol. 2009 May 20; 27(15_suppl):5060. PMID: 27962979.
    View in: PubMed
  57. Shen SH, Fennessy F, McDannold N, Jolesz F, Tempany C. Image-guided thermal therapy of uterine fibroids. Semin Ultrasound CT MR. 2009 Apr; 30(2):91-104. PMID: 19358440; PMCID: PMC2768544.
  58. Pilatou MC, Stewart EA, Maier SE, Fennessy FM, Hynynen K, Tempany CM, McDannold N. MRI-based thermal dosimetry and diffusion-weighted imaging of MRI-guided focused ultrasound thermal ablation of uterine fibroids. J Magn Reson Imaging. 2009 Feb; 29(2):404-11. PMID: 19161196; PMCID: PMC2754252.
  59. Fennessy FM, Tempany CMC, Kong C, Swan JS. Short-term utility analysis of fibroid treatment options and utility analysis of fibroid treatment outcomes. RSNA meeting program 2008. 2008; 433-434.
  60. Lénárd ZM, McDannold NJ, Fennessy FM, Stewart EA, Jolesz FA, Hynynen K, Tempany CM. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery--imaging predictors of success. Radiology. 2008 Oct; 249(1):187-94. PMID: 18695211; PMCID: PMC2657858.
  61. Ferenc Jolesz, Nathan McDannold, Greg Clement, Manabu Kinoshita, Fiona Fennessy, and ClareTempany . Image-Guided Interventions: Technology and Applications Chapter 10: "MRI-Guided FUS". Image-Guided Interventions: Technology and Applications. Editors: Terry Peters & Kevin Cleary . 2008.
  62. Fennessy FM, Tuncali K, Morrison PR, Tempany CM. MR imaging-guided interventions in the genitourinary tract: an evolving concept. Radiol Clin North Am. 2008 Jan; 46(1):149-66, vii. PMID: 18328885; PMCID: PMC3403748.
  63. Samuel A, Fennessy FM, Tempany CM, Stewart EA. Avoiding treatment of leiomyosarcomas: the role of magnetic resonance in focused ultrasound surgery. Fertil Steril. 2008 Sep; 90(3):850.e9-12. PMID: 18022163.
    View in: PubMed
  64. Sheehy, N; Fennessy F, Van den Abbeele A. The utility of 18F-FDG-PET in the diagnosis and management of colorectal carcinoma. Semin Colon Rectal Surg. 2007; 18:96-106.
  65. Fennessy FM, Tempany CM, McDannold NJ, So MJ, Hesley G, Gostout B, Kim HS, Holland GA, Sarti DA, Hynynen K, Jolesz FA, Stewart EA. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery--results of different treatment protocols. Radiology. 2007 Jun; 243(3):885-93. PMID: 17446521.
    View in: PubMed
  66. Suzuki A, Fennessy FM, Stewart EA, Fan CM, Tempany CM. . Spheres or Sound? A Comparison of Uterine Artery Embolization and Focused Ultrasound Surgery for Treatment of Uterine Fibroids . Educational Exhibit, RSNA. 2006.
  67. So MJ, Fennessy FM, Zou KH, McDannold N, Hynynen K, Jolesz FA, Stewart EA, Rybicki FJ, Tempany CM. Does the phase of menstrual cycle affect MR-guided focused ultrasound surgery of uterine leiomyomas? Eur J Radiol. 2006 Aug; 59(2):203-7. PMID: 16766153.
    View in: PubMed
  68. McDannold N, Tempany CM, Fennessy FM, So MJ, Rybicki FJ, Stewart EA, Jolesz FA, Hynynen K. Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology. 2006 Jul; 240(1):263-72. PMID: 16793983; PMCID: PMC1850234.
  69. Fennessy FM, Tempany CM. A review of magnetic resonance imaging-guided focused ultrasound surgery of uterine fibroids. Top Magn Reson Imaging. 2006 Jun; 17(3):173-9. PMID: 17414074.
    View in: PubMed
  70. A. Suzuki, F.M. Fennessy, K.H. Zou, C. Tempany . Magnetic Resonance Imaging characterization of uterine fibroids of African American women demonstrate an overall greater number of smaller uterine fibroids. ISMRM. 2006.
  71. Jati A, Fennessy F, Worth L, Chopra M, Jacobsen F. Retrospective review of the CT imaging characteristics of typical and atypical pulmonary carcinoids. ARRS. 2006.
  72. F M Fennessy, M J So, G K Hesley, K H Hynynen, E A Stewart, C M Tempany. Evaluation of the Safety and Efficacy of a Continued Access Study for MR-guided Focused Ultrasound Surgery (MRgFUS) of Uterine Fibroids. RSNA. 2005.
  73. So MJ, Rybicki F, Fennessy F, Stewart EA, Tempany C. Treatment outcome in MR-guided Focused Ultrasound Surgery for uterine fibroids: analysis of the effect of baseline uterine size and number of fibroids. RSNA. 2005.
  74. Fennessy FM, So MJ, McDannold N, Zou KH, Stewart EA, Tempany CM. Correlation of Volume Change 1-year post-MR guided Focused Ultrasound Surgery of Uterine Fibroids with Non-Perfusion Treatment Volume and Thermal Dose Volume. ISTU. 2005.
  75. F M Fennessy, M J So,N J McDannold, K H Zou, E A Stewart, C M Tempany, MD. Evaluation of Symptom Relief and Fibroid Reduction 1 Year following MR guided Focused Ultrasound Surgery. RSNA. 2005.
  76. Fennessy FM, Tempany CM. MRI-guided focused ultrasound surgery of uterine leiomyomas. Acad Radiol. 2005 Sep; 12(9):1158-66. PMID: 16099686.
    View in: PubMed
  77. F Fennessy, M J So, N J MacDonald, S J Haker, K J Zou, C M Tempany, K H Hynynen, F J Rybicki, F A Jolesz, E A Stewart. Six Months Post MR-guided Focused Ultrasound Surgery of Uterine Leiomyomas: Correlation of Volume Change with Non-Perfusion Treatment Volume and Sonication Number. RSNA. 2004.
  78. M J So, F M Fennessy, K Zou, E A Stewart, F Rybicki, C M Tempany, N McDannold, K Hynynen, F A Jolesz. Effectiveness of MR-guided Focused Ultrasound Surgery Treated Uterine Leiomyomas Correlated with Menstrual Cycle Phase. RSNA. 2004.
  79. Baeyens K, Fennessy F, Bleday R, Glickman J, Mortele KJ. CT features of a tubal lipoma associated with an ipsilateral dermoid cyst (2004:6b). Eur Radiol. 2004 Sep; 14(9):1720-2. PMID: 15316745.
    View in: PubMed
  80. Joyce M, Moore K, Thompson C, Fitzgerald P, Fennessy F, Kelly CJ, Bouchier-Hayes DJ. Hydroxy-methylglutaryl-coenzyme A reductase inhibition improves endothelial dysfunction in type-1 diabetes. Eur J Vasc Endovasc Surg. 2004 Apr; 27(4):432-7. PMID: 15015196.
    View in: PubMed
  81. Fennessy FM, Mortele KJ, Kluckert T, Gogate A, Ondategui-Parra S, Ros P, Silverman SG. Hepatic capsular retraction in metastatic carcinoma of the breast occurring with increase or decrease in size of subjacent metastasis. AJR Am J Roentgenol. 2004 Mar; 182(3):651-5. PMID: 14975965.
    View in: PubMed
  82. Oliva MR, Borges Oliva MR, Hsing J, Rybicki FJ, Fennessy F, Mortelé KJ, Ros PR. Glomerulocystic kidney disease: MRI findings. Abdom Imaging. 2003 Nov-Dec; 28(6):889-92. PMID: 14753613.
    View in: PubMed
  83. Fennessy F, Stewart A., Tempany C. Magnetic Resonance-guided Focused Ultrasound Surgery of Uterine Leiomyomas. J Women's Imaging. 2003; 5(4):171-176.
  84. Fennessy F, McDannold N, Stewart, E, Hynynen K, Tempany C. Nominal Orientation of MRI-guided focused ultrasound treatment of uterine fibroids induces greater leiomyoma necrosis. Proceedings of the Eleventh Meeting of the International Society for Magnetic Resonance in Medicine. 2003.
  85. Fennessy F, Casey RG, Bouchier-Hayes D. Peripheral and central arterial haemodynamic interactions are early abnormalities in young male cigarette smokers. Eur J Vasc Endovasc Surg. 2003 Feb; 25(2):152-8. PMID: 12552477.
    View in: PubMed
  86. Fennessy FM, Moneley DS, Wang JH, Kelly CJ, Bouchier-Hayes DJ. Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers. Circulation. 2003 Jan 28; 107(3):410-5. PMID: 12551864.
    View in: PubMed
  87. Tierney S, Fennessy F, Hayes DB. ABC of arterial and vascular disease. Secondary prevention of peripheral vascular disease. BMJ. 2000 May 06; 320(7244):1262-5. PMID: 10797042; PMCID: PMC1117996.
  88. Fennessy F., Gesner L., Bhadelia R. MR imaging of acquired abnormalities of the corpus callosum. ASNR Proceedings. 2000.
  89. Wu QD, Wang JH, Fennessy F, Redmond HP, Bouchier-Hayes D. Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am J Physiol. 1999 Dec; 277(6 Pt 1):C1229-38. PMID: 10600775.
    View in: PubMed
  90. Fiona M. Fennessy. Endothelial Physiology in Young Cigarette Smokers: A Multifunctional Analysis of the Effect of Taurine Supplementation. PhD thesis. 1999.
  91. Fennessy F., Wang JH, Kelly C., Bouchier-Hayes, D. Smoking and shear stress-induced endothelial cell anoikis may be prevented by the amino acid taurine. Surgical Forum. 1998; 290-292.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Fennessy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_